BIOMAT Database Logo BIOMAT Database Logo

Streptokinase resistance: when might streptokinase administration be ineffective? 1993

M Lynch, and B Pentecost, and W A Littler, and R A Stockley

UI MeSH Term Description Entries
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013300 Streptokinase Streptococcal fibrinolysin . An enzyme produced by hemolytic streptococci. It hydrolyzes amide linkages and serves as an activator of plasminogen. It is used in thrombolytic therapy and is used also in mixtures with streptodornase (STREPTODORNASE AND STREPTOKINASE). EC 3.4.-. Avelizin,Awelysin,Celiase,Distreptase,Kabikinase,Kabivitrum,Streptase,Streptodecase

Related Publications

M Lynch, and B Pentecost, and W A Littler, and R A Stockley
Streptokinase resistance: when might streptokinase administration be ineffective?
November 1992, British heart journal,
M Lynch, and B Pentecost, and W A Littler, and R A Stockley
When less might be more.
August 2012, American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics,
M Lynch, and B Pentecost, and W A Littler, and R A Stockley
Prostate cancer: Sequencing AR-targeted agents might be ineffective in mCRPC.
May 2015, Nature reviews. Urology,
M Lynch, and B Pentecost, and W A Littler, and R A Stockley
COVID-19: When more might be less.
June 2021, Nutrition, metabolism, and cardiovascular diseases : NMCD,
M Lynch, and B Pentecost, and W A Littler, and R A Stockley
Breast cancer: Tamoxifen--when more might be better.
March 2013, Nature reviews. Clinical oncology,
M Lynch, and B Pentecost, and W A Littler, and R A Stockley
When better still might not be good enough.
October 2017, Translational cancer research,
M Lynch, and B Pentecost, and W A Littler, and R A Stockley
[Scleritis: when might a systemic disease be involved?].
October 2010, Journal francais d'ophtalmologie,
M Lynch, and B Pentecost, and W A Littler, and R A Stockley
Epigenetics and cancer disparities: when nature might be nurture.
January 2022, Oncoscience,
M Lynch, and B Pentecost, and W A Littler, and R A Stockley
How and When Selection Experiments Might Actually be Useful.
June 2005, Integrative and comparative biology,
M Lynch, and B Pentecost, and W A Littler, and R A Stockley
What to do when it might be child abuse.
February 2009, The virtual mentor : VM,
Copied contents to your clipboard!